VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ not intending to move away from the clinic's       │ not intending to move away from the clinic's       │     100 │
│ catchment area for the next 2 years                │ catchment area for the next 2 years                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HIV-1 antibody negative                            │ HIV-1 antibody negative                            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ reports commercial sex work                        │ reports commercial sex work                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ contact information is provided                    │ contact information is provided                    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ written informed consent                           │ written informed consent                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HIV infection at screening                         │ HIV infection at screening                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ participation in previous or concurrent HIV        │ participation in previous or concurrent HIV        │     100 │
│ vaccine trials                                     │ vaccine trials                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ lactating, pregnant or planning pregnancy          │ lactating, pregnant or planning pregnancy          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ abnormal liver function tests (AST/ALT \> 43 U/L), │ abnormal liver function tests (AST/ALT > 43 U/L),  │     100 │
│ liver disease, viral hepatitis, hepatitis B virus  │ liver disease, viral hepatitis, hepatitis B virus  │         │
│ (HBV) infection                                    │ (HBV) infection                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ known sensitivity to components of the Truvada®    │ known sensitivity to components of the Truvada®    │     100 │
│ formulation                                        │ formulation                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ any immunosuppressive treatment, such as systemic  │ any immunosuppressive treatment, such as systemic  │     100 │
│ corticosteroids                                    │ corticosteroids                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ assumption of medication that interacts with       │ assumption of medication that interacts with       │     100 │
│ Truvada®                                           │ Truvada®                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ high likelihood of poor adherence to PREP and      │ high likelihood of poor adherence to PREP and      │     100 │
│ clinic attendance                                  │ clinic attendance                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ any condition that in the opinion of the attending │ any condition that in the opinion of the attending │     100 │
│ physician could endanger the health of the         │ physician could endanger the health of the         │         │
│ participant or render her unsuitable to            │ participant or render her unsuitable to            │         │
│ participate in the trial                           │ participate in the trial                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ age ≥18 at screening                               │ age =18 at screening                               │      95 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ renal function impairment (serum creatinine \>1.5  │ renal function impairment (serum creatinine >1.5   │      99 │
│ mg/dl), Fanconi syndrome                           │ mg/dl), Fanconi syndrome                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ serum phosphorus \<2.2mg/dl, osteoporosis          │ serum phosphorus <2.2mg/dl, osteoporosis           │      99 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                │   Score │
╞═══════════════════════════════════╪══════════════════════════════════════════════╪═════════╡
│ Must be FEMALE                    │ written informed consent                     │      21 │
├───────────────────────────────────┼──────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ not intending to move away from the clinic's │      37 │
│                                   │ catchment area for the next 2 years          │         │
╘═══════════════════════════════════╧══════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 92.15789473684211
OverAll Ratio: 94.57894736842105
